期刊文献+

纳洛酮治疗肝性脑病的临床效果

原文传递
导出
摘要 目的探讨纳洛酮治疗肝性脑病的临床效果。方法随机选取汝州市第一人民医院2012年12月至2014年10月收治的肝性脑病患者70例,按照治疗方案的不同将其分为观察组和对照组,对照组采用醒脑静治疗,观察组采用纳洛酮治疗,对两组患者的临床治疗效果及其临床症状的改善情况进行观察对比。结果观察组临床治疗总有效率明显高于对照组,差异有统计学意义(P〈0.05)。结论纳洛酮治疗肝性脑病效果显著,有助于保护患者脑功能,是一种有效的治疗方案。
出处 《中国实用医刊》 2016年第5期115-116,共2页 Chinese Journal of Practical Medicine
  • 相关文献

参考文献6

二级参考文献62

  • 1李晓青,董蕾,刘中华,罗金燕.肝性脑病大鼠GABA-A受体亚单位mRNA的表达[J].中华肝脏病杂志,2005,13(3):232-233. 被引量:1
  • 2Jain L, Sharma BC, Sharma P, et al. Serum endotoxin and inflammatory mediators in patients with cirrhosis and hepatic encephalopathy. Dig Liver Dis, 2012, 44: 1027-1031.
  • 3Parker T, Freilich S, Tidswell T, et al. Hepatic encephalopathy with epilepsia partialis continua: a case report. Seizure, 2012, 21: 813-815.
  • 4Seo YS, Vim SY, Jung JY, et al. Psychometric hepatic encephalopathy score for the detection of minimal hepatic encephalopathy in Korean patients with liver cirrhosis. J Gastroenterology Hepatol, 2012, 27: 1695-1704.
  • 5Corbett C, Mangat K, Olliff S, et al. The role of Transjugular Intrahepatic Portosystemic Stent-Shunt(TIPSS) in the management of variceal hemorrhage. Liver Int, 2012, 32: 1493-1504.
  • 6Zhang LJ, Zheng G, Zhang L, et al. Altered brain functional connectivity in patients with cirrhosis and minimal hepatic encephalopathy: a functional MR imaging study. Radiology, 2012, 265: 528-536.
  • 7Chiu J, Tang YF, Yao TJ, et al. The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits. Cancer, 2012, 118: 5293-5301.
  • 8Kappus MR, Bajaj JS. Covert hepatic encephalopathy: not as minimal as you might think. Clin Gastroenterol Hepatol, 2012, 10: 1208-1219.
  • 9Gaglio P, Marfo K, Chiodo J 3rd. Hyponatremia in cirrhosis and end-stage liver disease: treatment with the vasopressin V,-receptor antagonist tolvaptan. Dig Dis Sci, 2012,57: 2774-2785.
  • 10Montagnese S, Schiff S, Turco M, et al. Simple tools for complex syndromes: a three-level difficulty test for hepatic encephalopathy. Dig Liver Dis, 2012, 44: 957-960.

共引文献62

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部